These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19068202)

  • 41. The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.
    Kogure T; Mantani N; Goto H; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2002 Aug; 11(4):219-24. PubMed ID: 12396473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.
    Soiffer RJ; Murray C; Shapiro C; Collins H; Chartier S; Lazo S; Ritz J
    Clin Cancer Res; 1996 Mar; 2(3):493-9. PubMed ID: 9816195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self.
    Michen S; Frosch J; Füssel M; Schackert G; Momburg F; Temme A
    Cytotherapy; 2020 Jul; 22(7):354-368. PubMed ID: 32451262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR; Renauld JC; Houssiau FA
    Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture.
    Choi SS; Chhabra VS; Nguyen QH; Ank BJ; Stiehm ER; Roberts RL
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):879-88. PubMed ID: 15358647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury.
    Aronson FR; Libby P; Brandon EP; Janicka MW; Mier JW
    J Immunol; 1988 Jul; 141(1):158-63. PubMed ID: 3259966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapy.
    Favrot M; Capdeville R; Combaret V; Zhou DC; Clapisson G; Banchereau J; Franks CR; Chouaib S; Blay JY; Philip T
    Eur Cytokine Netw; 1990; 1(3):141-7. PubMed ID: 2129798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and validation of a clinically applicable culture procedure for the generation of interleukin-2 activated natural killer cells in human bone marrow autografts.
    Klingemann HG; Deal H; Reid D; Eaves CJ
    Exp Hematol; 1993 Aug; 21(9):1263-70. PubMed ID: 8330650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.
    Lapteva N; Durett AG; Sun J; Rollins LA; Huye LL; Fang J; Dandekar V; Mei Z; Jackson K; Vera J; Ando J; Ngo MC; Coustan-Smith E; Campana D; Szmania S; Garg T; Moreno-Bost A; Vanrhee F; Gee AP; Rooney CM
    Cytotherapy; 2012 Oct; 14(9):1131-43. PubMed ID: 22900959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12.
    Dowell AC; Oldham KA; Bhatt RI; Lee SP; Searle PF
    Cancer Immunol Immunother; 2012 May; 61(5):615-28. PubMed ID: 22021067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of FPIL6/IL2 on the differentiation and proliferation of lymphoid in the ML-IC assay].
    Fan EJ; Song JM; Xu SR; Zhao CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):30-5. PubMed ID: 12905836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ex vivo expansion of highly purified NK cells from human peripheral blood].
    Li XH; Ma J; Wang FF; Dou LP; Li M; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):373-7. PubMed ID: 17493350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15.
    Haraguchi K; Suzuki T; Koyama N; Kumano K; Nakahara F; Matsumoto A; Yokoyama Y; Sakata-Yanagimoto M; Masuda S; Takahashi T; Kamijo A; Takahashi K; Takanashi M; Okuyama Y; Yasutomo K; Sakano S; Yagita H; Kurokawa M; Ogawa S; Chiba S
    J Immunol; 2009 May; 182(10):6168-78. PubMed ID: 19414770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.
    Lim SA; Kim TJ; Lee JE; Sonn CH; Kim K; Kim J; Choi JG; Choi IK; Yun CO; Kim JH; Yee C; Kumar V; Lee KM
    Cancer Res; 2013 Apr; 73(8):2598-607. PubMed ID: 23580577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
    Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
    Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function.
    Satwani P; van de Ven C; Ayello J; Cairo D; Simpson LL; Baxi L; Cairo MS
    Cytotherapy; 2011 Jul; 13(6):730-8. PubMed ID: 21413839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood.
    Condiotti R; Zakai YB; Barak V; Nagler A
    Exp Hematol; 2001 Jan; 29(1):104-13. PubMed ID: 11164111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ex vivo expansion of CD56+ NK and NKT-like lymphocytes from peripheral blood mononuclear cells of patients with ovarian neoplasia.
    Alves PCM; De Angelo Andrade LAL; Petta CA; Lorand-Metze I; Derchain SF; Guimarães F
    Scand J Immunol; 2011 Sep; 74(3):244-252. PubMed ID: 21595734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Membrane-bound interleukin-21 and CD137 ligand induce functional human natural killer cells from peripheral blood mononuclear cells through STAT-3 activation.
    Wang X; Lee DA; Wang Y; Wang L; Yao Y; Lin Z; Cheng J; Zhu S
    Clin Exp Immunol; 2013 Apr; 172(1):104-12. PubMed ID: 23480190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.